In case you missed it...the new Ritedose.com is now live - keeping our passion, precision, and purpose at the forefront. Check it out! ➡️ ritedose.com
The Ritedose Corporation
Pharmaceutical Manufacturing
Columbia, SC 6,615 followers
Manufacturing | Inhalation | Ophthalmics | Sterile Liquids
About us
The Ritedose Corporation is a leader in blow-fill-seal(BFS) manufacturing of small fill volume pharmaceutical unit dose sterile and non-sterile liquids. We specialize in manufacturing inhalation products, eye drops, eardrops and unit dose oral liquids.
- Website
-
http://xmrrwallet.com/cmx.pwww.ritedose.com
External link for The Ritedose Corporation
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Columbia, SC
- Type
- Privately Held
- Founded
- 1995
- Specialties
- Contract Pharmaceutical Blow-Fill-Seal Manufacturer
Locations
-
Primary
1 Technology Circle
Columbia, SC 29203, US
Employees at The Ritedose Corporation
-
Joseph Boorady
Serial Entrepreneur I Independent Board Director l Global CEO l Investor l M&A l Medical Devices l Biotech l Private Equity I Business Development
-
Maris Lazdins
Regulatory Affairs Operations Specialist III at The Ritedose Corporation, (TRC)
-
Scot Thoroughman
Pharmaceutical Professional
-
Angie Koen
EVP Technical Services, The Ritedose Corporation
Updates
-
How important is analytical testing? Crucial, actually. And getting more so. 🔗 Read more below, and catch the full article here from Contract Pharma: https://xmrrwallet.com/cmx.ploom.ly/nexjBBE
-
Hear from our employees! 📣 At Ritedose, we strive to better the community around us by working for the greater good. Bonnie Kate W. , our Talent Acquisition Manager, shared that "Being able to be a part of an organization that is committed to having an impact in the Midlands is such a great feeling."
-
-
Now LIVE: The new Ritedose.com! Our new website reflects our innovation, serves our partners and showcases the mission that drives us all: Delivering high-quality medications with passion and precision. What’s New? ▪️ Modern, mobile-friendly design – Easier to navigate on any device. ▪️ Clearer storytelling – Our people, purpose, and products are front and center. ▪️ Updated product and service details – Better showcases our generics and CDMO capabilities. ▪️ And more! Check out the new site here ➡️ ritedose.com
-
A smarter future for U.S. pharmaceutical manufacturing is taking shape. A recent report from PitchBook points to a shift in how the industry responds to global pressures: from increasing U.S.-based production to investing in automation, AI, and efficiency. This evolution is about building better models that improve speed, reliability, and access for patients and providers alike. At Ritedose, we continue to expand our U.S. capacity and apply smart technologies to strengthen supply and deliver high-quality medications without interruption. 📖 Read the full article on Fierce Biotech: https://xmrrwallet.com/cmx.ploom.ly/8ud250k
-
-
🇺🇸 Happy 4th of July from all of us at Ritedose! Today, we celebrate the strength, resilience, and freedom that define our nation. We're proud to play a role in supporting the health and well-being of communities across the country. Wishing you a safe, joyful, and meaningful Independence Day with family and friends! ❤️🤍💙
-
-
Hear from our employees! 📣 Jane started working for Ritedose through the RISE Program after graduating from Benedict College. Thank you for your hard work and dedication, Jane! "Working in the lab with experts has exposed me to more aspects of chemistry and microbiology in the workforce and allows me to make valuable contributions" - Jane K.
-
-
Cybersecurity, CDMOs and AI Data breaches are becoming more common, and plague the safe, reliable production of much-needed medicines for patients. In a Contract Pharma column, Kiteworks CIO Frank Balonis details what pharmas and CDMOs can do to prevent breaches: ▪️ Consolidate communications tools into a single platform ▪️ Use AI to detect unusual data patterns and conduct real-time analysis of data use ▪️ Adopt zero-trust processes, requiring validation and identification of all users ▪️ Automate compliance reporting capabilities ▪️ Establish third-party risk management programs At Ritedose, we know our manufacturing data has a human side: the patients and caregivers who rely on our medicines. 🔗 Read the article here: https://xmrrwallet.com/cmx.ploom.ly/gfnIpS8
-
-
💙 We’re excited to roll up our sleeves for the next 1000 Hours of Purpose volunteering event—this time with Homeless No More! Our volunteers will support the children’s summer camp program, themed “Building the Future” 🛠️ Helping kids design and build their own cities to present later that week 🎨 Joining in fun activities like creating machines, tie-dyeing shirts, and more 🍕 Sharing a pizza lunch with the kids! It’s all about showing up for our community, inspiring creativity, and reminding kids they can build the future they dream of. 🔗 Learn more about Homeless No More: https://xmrrwallet.com/cmx.ploom.ly/3SXRIHU
-
-
Unit-dose drug manufacturing (production of single-use, prepackaged doses) is catching on fast. ▫️ According to a new report, the entire market was worth $18.4 billion in 2021 and is projected to reach $61.8 billion by 2028, a growth rate of 18.78%! ▫️ The report also lists Ritedose as a key player in the single-dose industry, making needed medicines safely and accurately! Read more here! ➡️ https://xmrrwallet.com/cmx.ploom.ly/sVdmayg
-